Literature DB >> 20203294

Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism.

Elia Ranzato1, Stefano Biffo, Bruno Burlando.   

Abstract

We studied the mechanism of ascorbate toxicity in malignant mesothelioma (MMe) cells. Neutral red uptake showed that ascorbate, but not dehydroascorbate, was highly toxic in the MMe cell lines REN and MM98, and less toxic in immortalized (human mesothelial cells-htert) and primary mesothelial cells. Ascorbate transport inhibitors phloretin, sodium azide, and ouabain did not reduce ascorbate toxicity. Ascorbate promoted the formation of H(2)O(2) in the cell medium, and its toxicity was suppressed by extracellular catalase, but the concentration of endogenous catalase was higher in MMe cells than in normal cells. The confocal imaging of cells loaded with the dihydrhodamine 123 reactive oxygen species probe showed that ascorbate caused a strong increase of rhodamine fluorescence in MMe cells, but not in mesothelial cells. MMe cells showed a higher production of superoxide and NADPH oxidase (NOX)4 expression than did mesothelial cells. Two inhibitors of cellular superoxide sources (apocynin and rotenone) reduced ascorbate toxicity and the ascorbate-induced rise in rhodamine fluorescence. NOX4 small interfering RNA also reduced ascorbate toxicity in REN cells. Taken together, the data indicate that ascorbate-induced extracellular H(2)O(2) production induces a strong oxidative stress in MMe cells because of their high rate of superoxide production. This explains the selective toxicity of ascorbate in MMe cells, and suggests its possible use in the clinical treatment of malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203294     DOI: 10.1165/rcmb.2009-0340OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.

Authors:  Myron K Evans; Artak Tovmasyan; Ines Batinic-Haberle; Gayathri R Devi
Journal:  Free Radic Biol Med       Date:  2013-12-12       Impact factor: 7.376

Review 2.  Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

Authors:  Nermi L Parrow; Jonathan A Leshin; Mark Levine
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

3.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

4.  Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage.

Authors:  Visarut Buranasudja; Claire M Doskey; Adrienne R Gibson; Brett A Wagner; Juan Du; David J Gordon; Stacia L Koppenhafer; Joseph J Cullen; Garry R Buettner
Journal:  Mol Cancer Res       Date:  2019-07-23       Impact factor: 5.852

Review 5.  Evaluation of vitamin C for adjuvant sepsis therapy.

Authors:  John X Wilson
Journal:  Antioxid Redox Signal       Date:  2013-06-25       Impact factor: 8.401

6.  Calculated cell-specific intracellular hydrogen peroxide concentration: Relevance in cancer cell susceptibility during ascorbate therapy.

Authors:  Dieanira Erudaitius; Jacqueline Mantooth; Andrew Huang; Jesse Soliman; Claire M Doskey; Garry R Buettner; Victor G J Rodgers
Journal:  Free Radic Biol Med       Date:  2018-03-27       Impact factor: 7.376

7.  Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines in vitro.

Authors:  Giovanni Vanni Frajese; Monica Benvenuto; Massimo Fantini; Elena Ambrosin; Pamela Sacchetti; Laura Masuelli; Maria Gabriella Giganti; Andrea Modesti; Roberto Bei
Journal:  Oncol Lett       Date:  2016-04-27       Impact factor: 2.967

8.  Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells.

Authors:  Saleha B Vuyyuri; Jacob Rinkinen; Erin Worden; Hyekyung Shim; Sukchan Lee; Keith R Davis
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

Review 9.  Oxidative stress induces mitochondrial DNA damage and cytotoxicity through independent mechanisms in human cancer cells.

Authors:  Yue Han; Junjian Z Chen
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

10.  Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.

Authors:  Viviana Volta; Elia Ranzato; Simona Martinotti; Simone Gallo; Maria Veronica Russo; Luciano Mutti; Stefano Biffo; Bruno Burlando
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.